DCTH News 3.74 Delcath Systems (DCTH)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Delcath Systems (DCTH) 3.74 $DCTH

ABIOMED's Impella RP Bags CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 5:50PM CDT
Shares of ABIOMED climbed 2.8% following the announcement last week, to close at $24.48 till the last closing date.

Accuray Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 1:50PM CDT
Accuray's year-over-year loss narrowed primarily due to robust top-line improvement of 20% from the year-ago period.

Balanced View of Luminex Corporation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 5:30PM CDT
Luminex is optimistic about the life science research market and foresees continued favorable trends with respect to demand from its clinical customers.

Varian Medical Systems Settles Patent Dispute - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 2:10PM CDT
According to VAR, part of the settlement will be expensed in the financial results of the second quarter while the balance will be recorded as a prepaid royalty in the third quarter of fiscal 2014.

Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 7:43AM CDT
AngioDynamics falls 7.8% last trading session, continuing the downtrend

AngioDynamics Q3 Earnings Flat but Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:28AM CDT
ANGO lowered its adjusted EPS guidance for fiscal 2014 to a range of 60 to 63 cents from the prior range of 63 to 67 cents.

Delcath Systems (DCTH) Worth Watching: Stock Soars 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:25AM CDT
Delcath Systems was a big mover last session, with shares surging over 20% on the day.

Masimo Reports Encouraging PVI Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:40PM CDT
The results demonstrated that MASI's non-invasive PVI parameter helps clinicians optimize fluid administration for abdominal surgical patients under combined general and epidural anesthesia.

Delcath Systems Shares Tank on Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 1:50PM CDT
Delcath has been going through a rough patch after it failed to win approval from U.S. Food and Drug Administration (FDA) for its Melblez liver cancer therapy device.

Cepheid (CPHD) Looks Good: Stock Adds 5.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:04AM CDT
Cepheid was a big mover last session, as the company saw its shares rise over 5% on the day.

Delcath (DCTH) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:58AM CDT
Delcath (DCTH) Enters Oversold Territory

Intuitive Surgical (ISRG) Crumbles: Stock Falls by 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:34AM CDT
Shares of Intuitive Surgical fell nearly 7% on the day. This continues the recent trend of the company, as the stock is now trading within the volatile price range of $422.1 to $540.6 in the past one-month time frame.

La Quint Holdings Makes its Debut on the NYSE; Electronics Arts Hires Amy Hennig for Star Wars Project
ACCESSWIRE - Wed Apr 09, 11:44PM CDT
La Quinta Holdings Inc. (NYSE: LQ) - For an in-depth report on La Quinta Holdings Inc. follow: www.BullTrends.com/stockquote/LQ

Varian Medical Systems Closes Velocity Software Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 2:20PM CDT
Post-acquisition, VAR expects its global sales, service and support network to contribute to faster and deeper market penetration for the Velocity product.

Intuitive Surgical Expects Lower Q1 Revs, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 1:50PM CDT
Per Intuitive Surgical, the deferrals will reduce Systems revenues by roughly $24 million and Instruments and Accessories revenues by $2 million.

Health Care Stocks Technical Coverage -- Research on Valeant Pharma Intl., Alkermes, Delcath Systems, and Acura Pharma
PR Newswire - Wed Apr 09, 7:35AM CDT
On Tuesday, April 08, 2014, the NASDAQ Composite ended at 4,112.99, up 0.81%, the Dow Jones Industrial Average edged 0.06% higher to finish the day at 16,256.14, and the S&P 500 closed at 1,851.96, up 0.38%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 659.34, down 0.80%, and the same has fallen by 3.36% in the previous three trading sessions. Investor-Edge has initiated coverage on the following equities: Valeant Pharmaceuticals International Inc. (NYSE: VRX), Alkermes PLC (NASDAQ: ALKS), Delcath Systems Inc. (NASDAQ: DCTH) and Acura Pharmaceuticals Inc. (NASDAQ: ACUR). Free technical research on VRX, ALKS, DCTH and ACUR can be downloaded upon signing up at:

Echo Therapeutics Slips to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 07, 1:50PM CDT
Echo Therapeutics' fourth-quarter reported loss per share more than doubled year over year to $3.9 million or 36 cents.

DexCom Shares Fall on FDA Warning - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:30PM CDT
Since the revelation of the warning letter, DexCom's shares dropped 5.7% to close at $41.95 yesterday.

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Teleflex Raised to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 1:50PM CDT
An encouraging guidance, increased M&A activity and stronger operating leverage represent a potential upside for Teleflex going forward.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 53

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 90

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 81

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 124

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 58

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 67

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 20

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 146

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading

Top 5 Most Recently Viewed Articles

Mary Kay's Continued Commitment to Sustainability Recognition

Updated Category News Views 342

Mary Kay's Commitment to Sustainability Recognized Again Mary Kay Inc., a global leader in skincare innovation and sustainability, has been recognized once more with the esteemed 2024 Texan by Nature 20 (TxN 20) award. This prestigious accolade, awarded by the non-profit organization Texan by Nature, highlights businesses in Texas that exemplify strong commitments to...

Continue Reading
A Bitcoin Whale Stirs After Years: What it Means for 2025

Updated Category News Views 549

Dormant Bitcoin Address Reawakens Recently, data from Blockchain tracker Whale Alert revealed the activity of a long-dormant Bitcoin address. This particular account has remained inactive for over 11 years and contains a significant holding of 357 BTC, estimated to be worth around $34,070,177 today. Such dormant addresses tend to generate intrigue within the...

Continue Reading
Artelo Biosciences Progresses with Innovative Pain Treatment Clinical Trials

Updated Category News Views 114

Artelo Biosciences Takes Significant Steps Forward Artelo Biosciences, Inc. (Nasdaq: ARTL), a pioneering clinical-stage pharmaceutical company, has achieved an important milestone with the successful completion of the first cohort in its Phase 1 study of ART26.12, a selective Fatty Acid Binding Protein 5 (FABP5) inhibitor. This marks a distinctive moment in the landscape...

Continue Reading
Empowering Youth: Leadership Growth Through Camp Initiatives

Updated Category News Views 303

Empowering Youth through Leadership Development at Camps Youth with disabilities and illnesses often face unique challenges that can impact their personal development and leadership skills. In a bid to address these challenges, a groundbreaking collaborative initiative has emerged, aimed at promoting character and leadership development in these young individuals. By...

Continue Reading
Understanding Man Group PLC's Recent Disclosure and Position

Updated Category News Views 251

Overview of Disclosures by Man Group PLC Man Group PLC recently submitted a significant disclosure in line with the Takeover Code, showcasing critical insights into their positions and dealings within the market. This comprehensive disclosure serves as an essential tool for analysts and investors alike to understand the company's strategic maneuvers, particularly with...

Continue Reading